<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-6NWCHP78</identifier><date>2012</date><creator>Anderluh, Franc</creator><creator>Oblak, Irena</creator><creator>Ocvirk, Janja</creator><creator>Velenik, Vaneja</creator><relation>documents/doc/6/URN_NBN_SI_doc-6NWCHP78_001.htm</relation><relation>documents/doc/6/URN_NBN_SI_doc-6NWCHP78_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-6NWCHP78_001.txt</relation><format format_type="issue">3</format><format format_type="volume">46</format><format format_type="type">article</format><format format_type="extent">str. 252-257, V</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">1362299</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-6NWCHP78</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antibodies, monoclonal</subject><subject language_type_id="slv">bolniki</subject><subject language_type_id="slv">danka</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Genes, RAS</subject><subject language_type_id="slv">mutacije</subject><subject language_type_id="eng">Mutation</subject><subject language_type_id="slv">novotvorbe</subject><subject language_type_id="slv">preživetje</subject><subject language_type_id="slv">radioterapija</subject><subject language_type_id="eng">Radiotherapy</subject><subject language_type_id="eng">Receptor, epidermal growth factor</subject><subject language_type_id="eng">Rectal neoplasms</subject><subject language_type_id="eng">Survival analysis</subject><subject language_type_id="eng">tumor</subject><title>Cetuximab in preoperative treatment of rectal cancer - term outcome of the XERT trial</title></Record>